Pre-visit sedation gains ground for fearful dogs and cats

Version 1

Veterinarians are continuing to refine a now-familiar strategy for getting fearful dogs and cats safely through clinic visits: pre-visit sedation and anxiolysis, most often with oral trazodone, gabapentin, or both, timed before transport and handling. While the supplied source appears to be a podcast entry from Dr. Andy Roark’s The Cone of Shame rather than a formal study, the broader evidence base supports the approach. In dogs, a randomized, placebo-controlled trial found that a single trazodone dose before transport reduced behavioral signs of stress during veterinary visits. In cats, multiple studies and feline handling guidelines support pre-visit gabapentin to reduce stress and improve exam compliance. Professional guidance from AAHA, AAFP, and Fear Free-aligned resources now frames these protocols as part of low-stress, safer care, not just a workaround for “difficult” patients. The same low-stress philosophy also shows up in veterinary podcast and education discussions about managing lunging, high-FAS dogs: rather than “just muzzle and get it done,” the emphasis is on behavior-aware handling, reducing triggers, and using medication when needed to avoid pushing patients and staff into unsafe situations. (pubmed.ncbi.nlm.nih.gov)

Why it matters: For veterinary teams, quick sedation is really about safety, welfare, and efficiency. Appropriate pre-visit pharmaceuticals can lower fear, anxiety, and stress, reduce injury risk for staff, improve the odds of completing exams and diagnostics, and sometimes prevent escalation to heavier injectable restraint or rescheduled appointments. It may also help address a less discussed issue in practice: the moral distress technicians and other staff can feel when they are repeatedly asked to force care on terrified animals or prolong handling that seems to worsen suffering. The main caveat is that protocols need to be individualized, especially for geriatric patients and those with renal, hepatic, or other comorbidities, and teams should set expectations with pet parents about timing, ataxia, and sedation effects. (pmc.ncbi.nlm.nih.gov)

What to watch: Expect continued emphasis on protocol-driven pre-visit medication plans, clearer client instructions, and more discussion of when oral sedation is enough versus when patients should move to in-clinic injectable sedation or anesthesia. Also watch for more explicit team conversations about staff safety and moral stress when handling high-FAS patients, including whether clinics build clearer “stop” points instead of defaulting to force-based restraint. (aaha.org)